PURPOSE: Studies using survey questionnaires to collect epidemiologic data rely on the accuracy of participants' self-reporting. As part of the quality control protocol for a large population-based case-control study of the association between postmenopausal hormone therapy (HT) and breast cancer in German women (the Mammakarzinom-Risikofaktoren-Erhebung [MARIE] study), the authors used test-retest to evaluate the reliability of women's self-reporting of a number of putative breast cancer risk factors, including HT, reproductive history, family history, and lifestyle. METHODS: Of those women interviewed between November 2002 and July 2003, 62 cases and 61 controls were re-interviewed an average of 10 months later, using a shortened version of the original study questionnaire. RESULTS: Agreement between the first and second interviews was assessed using Cohen's kappa and proportion of agreement. There was very good overall agreement between the two questionnaires for HT ever/never use (kappa = 0.90), type of therapy (kappa = 0.83), and form of application (kappa = 0.73) and good agreement for duration of use (kappa = 0.60). Agreement for other factors ranged from kappa = 1.00 for age at first birth to kappa = 0.43 for weekend bicycle riding. Agreement was nondifferential by disease status. CONCLUSIONS: These findings indicate that the MARIE survey instrument was of good quality and had a low likelihood of misclassification.
PURPOSE: Studies using survey questionnaires to collect epidemiologic data rely on the accuracy of participants' self-reporting. As part of the quality control protocol for a large population-based case-control study of the association between postmenopausal hormone therapy (HT) and breast cancer in German women (the Mammakarzinom-Risikofaktoren-Erhebung [MARIE] study), the authors used test-retest to evaluate the reliability of women's self-reporting of a number of putative breast cancer risk factors, including HT, reproductive history, family history, and lifestyle. METHODS: Of those women interviewed between November 2002 and July 2003, 62 cases and 61 controls were re-interviewed an average of 10 months later, using a shortened version of the original study questionnaire. RESULTS: Agreement between the first and second interviews was assessed using Cohen's kappa and proportion of agreement. There was very good overall agreement between the two questionnaires for HT ever/never use (kappa = 0.90), type of therapy (kappa = 0.83), and form of application (kappa = 0.73) and good agreement for duration of use (kappa = 0.60). Agreement for other factors ranged from kappa = 1.00 for age at first birth to kappa = 0.43 for weekend bicycle riding. Agreement was nondifferential by disease status. CONCLUSIONS: These findings indicate that the MARIE survey instrument was of good quality and had a low likelihood of misclassification.
Authors: M Kathryn Jedrziewski; Douglas C Ewbank; Haidong Wang; John Q Trojanowski Journal: Am J Alzheimers Dis Other Demen Date: 2014-01-08 Impact factor: 2.035
Authors: Amr Soliman; Katharine Allen; An-Chi Lo; Mousumi Banerjee; Ahmed Hablas; Abdellatif Benider; Nadya Benchekroun; Salwa Samir; Hoda G Omar; Sofia Merajver; Patricia Mullan Journal: Int Electron J Health Educ Date: 2009-01
Authors: M-H Tao; C Marian; P G Shields; N Potischman; J Nie; S S Krishnan; D L Berry; B V Kallakury; C Ambrosone; S B Edge; M Trevisan; J Winston; J L Freudenheim Journal: J Dev Orig Health Dis Date: 2013-04 Impact factor: 2.401
Authors: Caroline Linhart; Heribert Talasz; Evi M Morandi; Christopher Exley; Herbert H Lindner; Susanne Taucher; Daniel Egle; Michael Hubalek; Nicole Concin; Hanno Ulmer Journal: EBioMedicine Date: 2017-06-06 Impact factor: 8.143